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ABSTRACT
Trichomoniasis  has been linked to  pelvic  inflammatory disease,  cervical  cancer,  increased 
HIV transmission, infertility as well as co-infections with other STIs.  In 2002, an association 
was  found  with  Trichomonas  vaginalis and  PID  in  HIV  positive  women.  Therefore,  the 
question arose whether  T. vaginalis is able to invade the upper genital tract of HIV infected 
women. A prerequisite for invasion of the upper genital tract is the capability of the organism 
to adhere to the cells of the organs involved.  This study therefore investigated the interaction 
between T. vaginalis and vaginal, cervical and endometrial cells.
In comparing adhesion and cytotoxicity of T. vaginalis to cells of the upper and lower genital 
tract at different pH, immortalized vaginal (VK2), cervical (ME 180) and endometrial (KLE) 
cells were exposed to a standardized inoculum of trichomonads at pH 4.5 to 7.0. Adhesion was 
measured microscopically after acridine orange staining and cytotoxicity was established by 
measuring LDH release using a commercial kit.
Adhesion of the ME-180 and VK2 cell lines was found to be pH dependent.  However, the 
KLE cell  line  was  not.  As the  pH increased,  adherence  to  the  vaginal  and  cervical  cells 
decreased. Adhesion to endometrial cells was minimal at neutral pH but marked adhesion was 
found at lower pH. For the vaginal cell line, cytotoxicity was minimal at pH 4.5 but substantial 
(30 to  60%) at  higher  pH. In contrast,  cytotoxicity  on cervical  and endometrial  cells  was 
highest at lower pH. 
 
xii
The pronounced toxicity of vaginal epithelial cells at pH 5 and pH 5.5 is in keeping with the 
pH range found in patients with vaginitis. The observations on the cervical epithelium suggest 
toxic  effect  on  the  ecto-cervical  epithelium  immediate  after  acquisition  of  the  infection. 
Adhesion of trichomonads to the endometrial cell line suggests that T. vaginalis is capable of 
colonization  of  the  upper  genital  tract.   At  pH values  applicable  to  the  in  vivo situation, 





Sexually transmitted infections (STIs) are transmitted almost entirely via sexual contact with 
an infected person (Krieger & Alderete, 1999).  The most common infectious agents causing 
STIs are  Neisseria gonorrhoeae, the oculogenital biovars of  Chlamydia trachomatis, Herpes 
simplex virus 2 and Trichomonas vaginalis.
Trichomonas vaginalis is the only protozoal cause of sexually transmitted infections (Petrin et  
al., 1998).  Trichomoniasis, the disease caused by T. vaginalis is characterized by an abnormal 
vaginal discharge.  The inflammation of the vaginal epithelium results in redness, swelling and 
leukocyte infiltration (Zariffard et al., 2004).  More than 170 million people worldwide each 
year  are  infected  by  this  STI  (Ryu  &  Min,  2006).   Trichomoniasis  is  one  of  the  most 
commonly reported STIs  in  females  in  KwaZulu-Natal,  South Africa  (Moodley & Sturm, 
2004).  The prevalence has been reported as 28% among STD clinic attendees and 20% among 
antenatal clinic attendees (Moodley & Sturm, 2004).  
An association between  T. vaginalis infection and reproductive tract complications such as 
premature rupture of membranes has been reported (Cotch  et al., 1997).  Trichomoniasis is 
linked to various inflammatory diseases such as prostatitis, pelvic inflammatory disease (PID) 
as well as to increased HIV transmission (Draper et al., 1998; Petrin et al., 1998; Moodley et  
al., 2002; Skerk et al., 2002).  It is also associated with infertility in men and women as well 
as co-infections with other STIs (Petrin et al., 1998).    
Pelvic inflammatory disease is caused by micro-organisms such as  Neisseria gonorrhoeae,  
Chlamydia  trachomatis and  the bacterial  vaginosis  associated  organisms  (Moodley  et  al., 
2002).  In symptomatic women, the spread of infection from the cervix to the endometrium, 
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uterine tubes and concomitant structures results in abdominal pain accompanied by painful 
urination,  vaginal  discharge  and  fever  (CDC,  1995;  CDC,  2006).   The  association  of  T.  
vaginalis and pelvic inflammatory disease in HIV positive women, suggests that co-infection 
with  HIV  may  alter  the  host-microbe  relationship  resulting  in  an  increased  risk  of  PID 
(Moodley et al., 2002).  The authors hypothesize that either HIV infection allows T. vaginalis  
to migrate into the internal upper genitalia or that vaginal trichomoniasis facilitates ascending 
bacterial infections in HIV infected women.  One of the factors that might facilitate migration 
up the genital tract is the possibility of T. vaginalis to attach to the cells of the upper genital 
tract.  This study addresses the question whether T. vaginalis is able to adhere to the cells of 
the upper genital tract and whether the effect of interaction with these cells differs from those 





2.1 History and morphology of Trichomonas vaginalis
2.1.1 History
Little is known about the discovery and history of  Trichomonas vaginalis.  In 1836, Alfred 
Francois  Donné  microscopically  observed  both  the  appearance  and  size  of  the  protozoan 
which  he  referred  to  as  ‘Trichomonas’  based  on  its  similarity  with  Tricodes  and  Monas 
(Thorburn,  1974).   Later,  Ehrenberg,  a  professor  of  Protozoology  pointed  out  that  the 
protozoan’s  human  habitat  is  vaginal  and  therefore  specifically  named  the  protozoan 
Trichomonas vaginalis (Thorburn, 1974). 
Trichomonas vaginalis was  initially  considered  to  be non-pathogenic  because  most  of  the 
infected patients were asymptomatic.  In 1942, Hesseltine found that 13% of female patients 
inoculated with  T. vaginalis  culture had developed trichomoniaisis (Hesseltine  et al., 1942). 
In 1953, Lanceley & McEntegart inoculated five male volunteers with  T. vaginalis culture, 
three of which developed urethritis (Lanceley & McEntegart, 1953).
2.1.2 Morphology
Trichomonas vaginalis is a prokaryotic organism with a eukaryotic nucleus.  It belongs to the 
Sub-Kingdom Protozoa and Sub-Phylum Mastigophora, which means “Flagella bearers”.  The 
family  of  Trichomonadidae  consists  of  seven  genera:  Trichomonas,  Pentatrichomonas,  
Tetratrichomonas,  Pentatrichomonoides,  Trichomitopsis,  Pseudotrypanosoma  and 
Cochlosoma (Cepicka et al., 2006).   Trichomonas vaginalis is the largest of three species of 
the  genus  Trichomonas inhabiting  man.   The  other  two  are  Trichomonas  hominis and 
Trichomonas tenax.  Trichomonas vaginalis is characterized by having trophozoites or feeding 
stages only (Petrin  et al., 1998).   This means that no cystic, environmental resistant form 
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exists.   This  explains  the  need  for  transmission  through  direct  contact  between  mucosal 
surfaces.  
The organism as shown in Figure 2.1 is microscopic in size (approximately 10µm long and 
7µm wide) and complex in structure, physiology and behaviour.  The oval trophozoite has a 
short  undulating membrane,  four flagella  (filamentous outgrowths of the ectoplasm) and a 
clearly  visible  barb-like  axostyle  (Alderete  et  al.,  1995c).   The axostyle  may be  used  for 
surface attachment  to vaginal  epithelial  cells  (VECs) causing tissue damage (Petrin  et  al.,
1998).  Trichomonas vaginalis  also has a basic cytostome or gullet (mouth aperture) which 
helps to maintain the intraluminal position.  In vitro, trichomonal cells appear ovoid or pear-
shaped whereas in the presence of VECs, they display an amoeboid appearance (Arroyo et al., 
1993).   In culture, the dividing growth phase contains several oversized round forms either 
without flagella or with flagella equipped with a dividing nucleus or multiple nuclei.  
Trichomonas vaginalis is highly sensitive to both atmospheric oxygen and the lack of moisture 
and will therefore not survive for more than a few hours outside of the body.         
Figure 2.1 An illustration of Trichomonas vaginalis
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2.2 Reproduction and life cycle
Trichomonas vaginalis multiplies by means of longitudinal binary fission.  While the nuclear 
divisions in other protozoans are either mitotic or meiotic,  trichomonads are an exception. 
They reproduce  by a  special  type  of  closed  mitosis  called  cryptopleuromitosis,  a  process 
similar to that of prokaryotic cells.  Figure 2.2 illustrates the process of cryptopleuromitosis 
which involves the development of spindle microtubules from two attractophores flanking the 
nucleus.  These spindle microtubules extend into the nucleus and attach to the kinetochores of 
the chromosomes.  These spindle microtubules also elongates between the two attractophores 
ultimately separating the two daughter cells. Each daughter cell reconstructs by producing any 
missing organelles (Petrin et al., 1998; Noël et al., 2003). 
     
Figure 2.2 The process of cryptopleuromitosis.  The spindle tubules (ST) stretch between two 
attractophores (A) and the kinetochores (K) of the surface of the nucleus. 
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2.3 Cell function
Trichomonas  vaginalis  lacks  important  eukaryotic  organelles,  such  as  mitochondria, 
peroxisomes  and  enzymes  needed  to  conduct  oxidative  phosphorylation.   Nutrients  are 
obtained  by  both  phagocytosis  and  transport  through  the  cell  membrane.   Trichomonas 
vaginalis produces  adenosine  triphosphate  (ATP),  by utilizing  enzymes  typically  found in 
anaerobic bacteria.   They do so by means of a unique, double membrane-bound organelle 
called the hydrogenosome.  These anaerobic mitochondria equivalents divide via fission and 
produce ATP via substrate phosphorylation (Palmer, 1997).  However, they differ from real 
mitochondria  in  that  they  do  not  contain  genetic  material  and  lack  cytochromes  (Palmer, 
1997).
The controversy surrounding mitochondrial symbiosis and divergence of trichomonads from 
the main eukaryotic tree was resolved by a study showing the presence of VaIRS proteins and 
mitochondrial  heat  shock proteins in  T. vaginalis.   This study suggests  that  mitochondrial 
symbiosis had occurred first (Hashimoto et al., 1998; Germot & Philippe, 1999).
2.4 Epidemiology
Trichomoniasis  is  a  sexually  transmissible  infection  that  is  capable  of  causing  substantial 
morbidity (Valadkhani et al., 2003).  Trichomonas vaginalis is the only pathogenic species of 
the genus Trichomonas and has a worldwide distribution.  The disease affects individuals in 
all racial groups and depending on the type of sub-population studied prevalence rates vary 
between 0 and 65% (Lossick,  1990a).  In men,  the organism can be found in the urethra, 
periurethral glands, prostate, epididymis, and in semen (Krieger, 1995).  
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In  2001,  WHO  estimated  that  174  million  cases  occur  worldwide  annually,  making  T.  
vaginalis infection the most common non-viral STI (WHO, 2001).  In the US, trichomoniasis 
affects two to three million women annually.  Reports from China indicate that it accounts for 
more than 30% of gynaecologic inflammatory diseases causing female sterility (Chen et al., 
2004).  A Korean study done on patients complaining of vaginal symptoms found that 10.4% 
of these patients were infected by T. vaginalis (Ryu & Min, 2006).  
The prevalence of trichomoniasis at STD clinics varies from eight to 31% (WHO, 2001).  In 
KwaZulu-Natal, trichomoniasis is one of the most commonly reported STIs in females.  A 
prevalence rate of 28% among STD clinic attendees was reported in 2004 (Moodley & Sturm, 
2004).
It was found that the prevalence of trichomoniasis was lower in women attending antenatal 
clinics (Johnson et al., 2005).  Studies done, amongst pregnant women in South Africa show 
prevalence rates between 15 and 41.4% (Sturm et al., 1998; Moodley & Sturm, 2004; Frohlich 
et al., 2007).  
These figures underestimate the real  prevalence,  since up to one half  of all  infections  are 
asymptomatic  and never  diagnosed.   Asymptomatic  carriers  can  unknowingly  transmit  T.  
vaginalis  via  unprotected  sexual  contact.   Therefore,  asymptomatic  infections  are 
epidemiologically important.    Sexual intercourse is the most common route of transmission. 
Trichomonas vaginalis can survive for several hours outside the host; however, non-venereal 
transmission is extremely rare (Heine & McGregor, 1993).
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2.5 Clinical manifestation, diagnosis and treatment
2.5.1 Clinical manifestation
Trichomonas vaginalis  mainly infects the squamous epithelium of the female genital  tract. 
This  organism  has  previously  been  found  in  the  urethra,  fallopian  tubes  and  the  pelvis 
(Upcroft  & Upcroft,  2001).  Clinically  trichomoniasis  varies  from an asymptomatic  carrier 
state to overt vaginitis.   This however, depends on the severity of the disease (Wisdom & 
Dunlop, 1965).  One third of asymptomatic women display clinical trichomoniasis within six 
months (Heine & McGregor, 1993).
Acute  trichomoniasis  is  characterized  by  diffuse  vulvitis  and  vaginitis  with  pruritis, 
dyspareunia and dysuria (Heine & McGregor, 1993).  Small  punctuate haemorrhagic spots 
often appear  on the cervical  mucosa,  a  situation termed the “strawberry cervix”  (Wolner-
Hanssen  et  al.,  1989;  Rein,  1989).   Symptoms  include  a  profuse,  mucopurulent,  frothy, 
malodorous, yellow or greenish discharge (Wolner-Hanssen et al., 1989; Petrin et al., 1998). 
In  this  stage,  the lactobacilli  which form the normal  vaginal  flora  have  been replaced  by 
anaerobic flora similar to that found in bacterial vaginosis.  However, asymptomatic women 
have a  normal  vaginal  pH with normal  vaginal  flora  (Wisdom & Dunlop,  1965;  Fouts  & 
Kraus, 1980).  This state of infection is termed the “carrier stage”.
  
The clinical signs exacerbate with menstruation and often improve during pregnancy (Heine & 
McGregor, 1993).  It is thought that menstrual blood causes a rise in pH creating an ideal 
environment  for  trichomonad  reproduction  (Goode  et  al.,  1994).   Also,  the  elevated  iron 
concentration in menstrual fluid aids in activating various pathogenic mechanisms, such as 
cysteine proteinases (Petrin et al., 1998).  The hormone estrogen, which levels are decreased 
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during menstruation, has been shown to inhibit a pathological protein known as cell detaching 
factor (Garber et al., 1991).
This organism has been associated with reproductive tract complications, such as premature 
rupture  of  membranes,  low  birth  weight,  cervical  cancer,  infertility,  as  well  as  HIV 
transmission (Rein, 1989; Heine & McGregor, 1993; Draper et al., 1998).  Trichomoniasis is 
predominant  in  women,  but  men  are  considered  as  asymptomatic  carriers  of  this  disease. 
Symptomatic cases, such as urethral discharge, urethritis and prostatitis have been reported in 
33% to 50% of male trichomonal infections (Krieger, 1995).  Also noted is the link between 
T. vaginalis and various complications including pelvic inflammatory disease and infertility 
(Krieger, 1995). 
2.5.2 Diagnosis
Clinical diagnosis is unreliable because symptoms and signs are often similar to those of other 
STDs (Rein & Holmes, 1983).  For example, an elevated vaginal pH measured using Nitrazine 
paper is suggestive of both trichomoniasis and bacterial vaginosis (BV). The release of a fishy 
odour upon application of 10% potassium hydroxide (potassium hydroxide amine test) is also 
suggestive of both trichomoniasis and BV.
Trichomoniasis,  is  therefore  diagnosed  by  means  of  laboratory  tests  like  microscopic 
examination  of  the  discharge,  preferably  using  staining  techniques,  by  culture  or  by 
polymerase chain reaction (PCR).  Polymerase chain reaction based tests have a sensitivity 
and specificity in the order of 97% to 98% (Heine  et al., 1997; Lin  et al., 1997).  Recently 
developed,  was  a  diagnostic  PCR  which  detects  low  concentrations  of  organisms  by 
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incorporating primers based on repetitive sequences in the T. vaginalis genome (Ryu & Min, 
2006).  In addition, oligonucleotide probes, monoclonal antibody dot blot assays and many 
more have been developed to detect  T. vaginalis  (Gombosova & Valent, 1990; Briselden & 
Hillier, 1994; Muresu et al., 1994).
The ‘gold standard’ broth culture is by far the most efficient, easy, valuable and economical 
tool for obtaining an accurate diagnosis (Lossick & Kent, 1991; Bhatt et al., 1996; Carr et al., 
1998).  However, culture needs an incubation period of two days.  Therefore, culture is not 
suitable  for  patient  management  as  treatment  needs  to  be  commenced  immediately. 
Monoclonal antibodies (MAbs) have been used for rapid detection as well as identification of 
isolates of cultured  T. vaginalis (Krieger  et al., 1985a).  Tests, such as  Trichomonas Direct 
Enzyme Immunoassay may be completed within one hour, permitting immediate diagnosis 
and treatment.  However, the sensitivity of these tests is lower than that of culture or PCR.
2.5.3 Treatment
Metronidazole,  a  5-nitroimidazole  is  currently  used for the treatment  of human urogenital 
trichomoniasis (Hrdy et al., 2005).  Even though other members of the nitroimidazole class are 
structurally related and differ in pharmacokinetic and therapeutic activities, they can also be 
used to treat this infection (Lau et al., 1992; Mathisen & Finegold, 1992; Gillis & Wiseman, 
1996).  A single oral dose of 2g metronidazole effectively treats trichomoniasis (CDC, 2006). 
However, this single dose is associated with gastrointestinal side effects and has a sub-optimal 
effect on Bacterial vaginosis (BV). 
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Because there is no protective immunity, re-infections are common.  In preventing re-infection 
and  reducing  transmission,  it  is  recommended  that  both  partners  be  concurrently  treated 
(Swygard et al., 2004; CDC, 2006).    
There is emergence of metronidazole resistance in vivo and in vitro.  Prevalence rates of 2.5% 
and  5%  have  been  reported  (Schwebke  &  Barrientes,  2006).   However,  the  correlation 
between this and non-response to treatment (in vivo resistance) is not clear and needs further 
elucidation.  Several different dose regimens have been proposed to eradicate metronidazole 
resistant trichomoniasis.  It has been suggested, to increase the dose of the drug in the case of 
refractory infection.  Some cases require prolonged treatment with such high doses that these 
need to be intravenously administered in order to reduce gastrointestinal side effects (Lossick, 
1990b; Narcisi & Secor, 1996).  
Metronidazole activation occurs within the hydrogenosome where it is reduced to cytotoxic 
anion radicals by pyruvate-ferredoxin oxidoreductase.  The electrons required for activation 
are released from pyruvate and transferred to the nitro group of metronidazole by ferredoxin, a 
low-redox-potential  carrier  (Hrdy  et  al.,  2005).   This  reductive  activation  creates  a 
concentration  gradient,  allowing more  of  the drug to enter  the cell.  These highly reactive 
radicals  cause  damage  to  cellular  DNA resulting  in  death  (Edwards,  1993).   It  has  been 
hypothesized that poorly functional hydrogenosomal oxidases, in resistant strains, results in an 
increased oxygen concentration.   Oxygen,  an important  competitor  for available  electrons, 
competes with the drug resulting in little reduction of the nitro group, oxidizing the nitro-free 
radicals to the original compound (Lewis et al., 1997).
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2.6 Host defence mechanisms
Although recurrent infections are common, the infection does not appear to confer immunity. 
However, immunity to T. vaginalis infection may be important in restricting the organism to 
the genito-urinary tract by stimulating non-specific responses (Ackers, 1990). These responses 
include complement activation via the alternative pathway as well as neutrophil phagocytosis 
(Shaio & Lin, 1995; Petrin et al., 1998).
Infection caused in men is short-lived and this could be due to the presence of zinc in the 
prostatic fluid which has been shown to be cytotoxic to T. vaginalis, and therefore may be an 
inhibiting factor (Daly et al., 1990).  Also, the reducing environment of the vagina is sufficient 
to activate proteinases involved in pathogenesis.  However, the male genital tract is oxidative, 
thereby inhibiting such mechanisms (Alderete & Provenzano, 1997). 
The ecology of the vaginal tract  during the reproductive years proves highly significant in 
determining the severity of infection.  Infection in the pre-menarchal girl and post-menopausal 
women is generally mild and transient as compared to women of the reproductive age.  This is 
due to possible pathogenic factors, such as the vaginal pH, iron concentrations in menstrual 
flow  and  estrogen  fluctuations  (Rein,  1989).  Dependability  of  the  organism  to  iron 
concentrations in the secretions is apparent.  When iron supply is low, it migrates deeper into 
the female genital tract in search of richer iron supply resulting in infection (Rein, 1989).  It is 
amazing how this organism survives dramatic environmental changes, such as the influx of 
host macromolecules, erythrocytes, serum constituents and pH changes.  Research focusing on 




Trichomonas vaginalis elaborates several mechanisms that contribute to pathogenesis during 
infection  (Zariffard  et  al.,  2004).   Being  the  most  intensely  studied  trichomonad,  these 
pathogenic  mechanisms  have  not  been  clearly  elucidated.   Mechanisms  utilized  by  this 
parasite include: interaction with the vaginal flora, immune evasion, recognition and binding 
to  mucin,  cytoadherence  mediated  by  adhesins,  haemolysis  and  the  excretion  of  soluble 
factors, degrading all immunoglobulin subclasses and complement (Petrin et al., 1998; Lehker 
& Sweeney, 1999; Alderete et al., 2002).  The surface of the organism is a vital component of 
the  complex  host-parasite  interaction.   The  fact  that  T.  vaginalis is  capable  of  long term 
survival in the adverse vaginal milieu demonstrates the highly evolved nature of this organism 
(Alderete et  al.,  2002).   Focusing  on  the  initial  stages  of  infection  provides  a  clearer 
understanding of the pathogenesis of T. vaginalis.  This in turn, could aid in developing new 
intervention strategies, better treatment, and better disease control.
2.7.1 Interaction with vaginal flora
The normal vaginal pH is very acidic (4.5 to 5.0) but T. vaginalis can survive in this milieu. 
The  increase  in  pH  due  to  infection  results  in  a  decrease  or  complete  loss  of  vaginal 
lactobacilli  and  an  increase  in  anaerobic  bacteria.   This  inverse  relationship  between 
T. vaginalis and vaginal lactobacilli is not completely understood.  Trichomonas vaginalis is 
capable  of phagocytising bacteria,  including lactobacilli  (Rendon-Maldonado  et al.,  1998). 
Furthermore, soluble factors secreted by T. vaginalis such as proteinases may destroy them.
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2.7.2 Immune evasion
An  important  aspect  of  pathogenesis  is  the  ability  to  evade  the  host  immune  system, 
comprising of both the innate and adaptive immune responses.  The innate immune system is 
the key mechanism of host resistance to many organisms, during the early stages of infection 
(Scharton-Kersten & Sher, 1997; Tiwari et al., 2008).  In 2004, Chang et al. found that during 
the  early  stages  of  adhesion,  T.  vaginalis rapidly  activated  nuclear  factor-κB (NF-κB)  in 
macrophages,  resulting  in  the  inhibition  of  pro-inflammatory cytokine  production.   It  was 
therefore suggested, that the organism induces an inhibitory mechanism in order to evade host 
immunity (Chang et al., 2004).
The secretion of large quantities of soluble antigens by  T. vaginalis may prevent the direct 
attack  of  antibodies  or  lymphocytes  on  the  organism  (Mason  &  Patterson,  1985). 
Trichomonas  vaginalis employs  a  phenotypic  variation  of  P270,  an  immunogenic 
glycoprotein, as a mechanism of immune evasion.  The organism may or may not express this 
immunogenic  glycoprotein.   The  immunogenic  glycoprotein  P270 is  alternately  expressed 
with adhesins (AP65, AP51, AP33 and AP23) on the surface of the organism.  Trichomonas 
vaginalis is therefore designated as P270+ for those organisms expressing the immunogen, 
and P270- for those lacking the immunogen. This antigenic variation could be an important 
step in host immune evasion.  In vitro, the shift from a heterogeneous population to P270- 
organisms expressing the adhesions enables greater adherence to VECs (Alderete & Kasmala, 
1986; Alderete et al., 1986; Alderete, 1988).   
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“Trichomonas vaginalis activates the alternative pathway of complement” (Petrin et al., 1998). 
Cervical mucus was found to be deficient in complement; therefore menstrual blood is the 
only source of vaginal complement (Alderete et al., 1995d).  
Iron was found to be a contributing factor in complement resistance.  When grown in vitro in 
iron-enriched  medium,  T.  vaginalis h as  b een  sh o wn  to  b e resistan t to  cell  lysis  v ia  th e 
alternative pathway of complement (Alderete  et al., 1995d).  In vivo, lactoferrin, a principle 
source of iron for the organism, confers resistance to complement mediated cell lysis.  It has 
been  suggested,  that  lactoferrin  is  responsible  for  up-regulating  expression  of  the  gene, 
encoding the cysteine proteinases that degrade the C3 portion of complement (Alderete et al., 
1995d).   During menses, when the microenvironment is saturated with erythrocytes, proteins, 
immunoglobulins  and  complement,  symptoms  of  trichomoniasis  are  exacerbated.   These 
erythrocytes  provide  T.  vaginalis  with  an  abundant  source  of  iron.   This  results  in  the 
expression of cysteine proteinases, allowing the organism to evade complement destruction 
(Alderete et al., 1995d). 
In addition to C3, cysteine proteinases secreted by the organism degrades immunoglobulins 
IgG, IgM and IgA.  This in turn, results in antibody destruction thus avoiding antibody attack 
(Hernandez-Gutierrez et al., 2004).
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2.7.3 Adherence and adhesins (contact dependent cytotoxicity)
A vital requirement of T. vaginalis for infection is the ability to adhere to VECs (Alderete & 
Garza, 1985).  Cell attachment is time, temperature and pH dependent (Arroyo et al., 1992). 
Trichomonas vaginalis not only interacts with VECs in vitro, but has also been observed to 
kill VECs (Krieger et al., 1985b).
Successful colonization of the vagina by the parasite is a complex multi-step process, initiated 
by interactions with mucin, a large glycoprotein and major constituent of mucus (Lehker & 
Sweeney, 1999; Alderete et al., 2002).  Many factors of T. vaginalis are involved in breaching 
the  mucous  layer.   Epithelial  adherence  is  mediated  by five  adhesion  proteins  designated 
AP120,  AP65,  AP51,  AP33,  and  AP23  (Garcia  &  Alderete,  2007),  acting  in  a  specific 
receptor-ligand fashion (Alderete  et al.,  1995c; Alderete  et al., 2002).  Gene expression is 
regulated at the transcriptional level by iron (Alderete et al., 1995c; Alderete et al., 1995d). 
Trichomonas  vaginalis requires  high  concentrations  of  iron  for  growth  and multiplication 
(Alderete et al., 2004).  The binding of lactoferrin results in an increased uptake of iron, which 
regulates adherence (Lehker et al., 1991; Lehker & Alderete, 1992).  In 2004, Alderete et al. 
reported that heme not only aids multiplication in an iron-limiting medium, but also increases 
“transcription  and  surface  placement  of  the  AP65  adhesin”,  thereby enhancing  adherence 
(Alderete  et al., 2004).  Haemoglobin and lactoferrin receptors, involved in iron acquisition, 
are located on the surface of the parasite, and may contribute to the organism’s survival in 
sites of different nutritional compositions within the host (Alderete et al., 2004).
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Recent findings illustrating the complexity of  T. vaginalis in its interaction with fibronectin 
(FN) contributes to the understanding of the nature of infection.   The parasite specifically 
binds to surface receptors by means of immobilized FN (Alderete et al., 2002).  The amount 
and affinity of bound FN is influenced by both iron and calcium concentrations (Crouch et al., 
2001;  Alderete et  al.,  2002).   This  indicates  that  depending  on  the  iron  status  of  the 
environment, calcium may influence recognition and binding to FN at sites of infection other 
than  the  surface  epithelium.   This  mechanism  may  permit  this  organism to  parasitize  at 
multiple host sites (Crouch et al., 2001).
Adhesin synthesis is up-regulated when the parasite comes in contact with a cell (Kucknoor et  
al., 2005a).  It has been reported, that the opposite side of the undulating membrane of the 
parasite harbors high concentrations of adhesins and microfilaments (Alderete & Garza, 1985; 
Rasmussen et al., 1986).  Therefore, this side is used for attachment to epithelial cells. 
Another  mechanism  of  pathogenesis  is  alternating  surface  expression  of  macromolecules 
(Alderete et al., 2002).  As discussed earlier, glycoprotein P270 is alternately expressed with 
adhesins on the surface of the parasite, and has been implicated with a variation in adhesion to 
epithelial  cells  (Alderete,  1988;  Alderete  & Garza,  1988;  Alderete  et  al.,  1992).   It  was 
observed, that adherent negative organisms expressed P270 whereas adherent positive did not 
(Alderete & Garza, 1988).  
Laminin,  a  glycoprotein  restricted  to  the  epithelial  basement  membrane,  promotes  cell 
adhesion  (Costa  e  Silva  Filho  et  al.,  1988).   The  parasite’s  receptors  may play  a  role  in 
pathogenesis.  Unlike adhesins, laminin-binding proteins spans over the entire surface of the 
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parasite.  Trichomonas vaginalis was found to adhere to laminin-coated plastic (Costa e Silva 
Filho et al., 1988).  
2.7.4 Haemolysis
Trichomonas vaginalis cannot synthesize de nova pyramidines,  purines and fatty acids and 
therefore relies on its environment to supply these substances.  Trichomonas vaginalis has the 
ability to lyse erythrocytes,  thereby acquiring an ideal source of fatty acids (Tiwari  et al., 
2008).  Apart from lipids, iron is also acquired via haemolysis (Rosset et al., 2002; Tiwari et  
al., 2008).  
Haemolysis  is a three step process (Rosset  et al., 2002) incorporating adhesion molecules. 
Trichomonads attach to erythrocytes in a specific ligand-receptor fashion.  This triggers the 
release  of  perforin-like  proteins,  such  as  cysteine  proteinases,  resulting  in  trichomonad 
detachment and erythrocyte lysis (Rosset et al., 2002).   In vitro, haemolysis occurs mostly at 
pH 4.5 suggesting the suitability of the normal vaginal milieu for such activity (Fiori  et al., 
1993; Rosset et al., 2002).
It has been reported, that the cell-free filtrates of T. vaginalis are capable of erythrocyte lysis 
(Pindak et al., 1993).  The cause of this effect was assumed to be the metabolic products of T.  
vaginalis, such as fatty acids.  It was also established that as the pH increased above 5.0, the 




Trichomonas vaginalis contains several surface proteinases, reported to play an important role 
in  pathogenesis  (Hernandez-Gutierrez  et  al.,  2004).   The  isolation  and  purification  of  T. 
vaginalis proteinases have been achieved permitting study of these enzymes  (Irvine  et al., 
1993; Irvine et al., 1997).  Trichomonas vaginalis has been reported to have between 11 and 
23 distinct cysteine proteinases, including those found on the cell surface and excreted by the 
parasite  (Arroyo  &  Alderete,  1989;  Provenzano  &  Alderete,  1995).   Various  cysteine 
proteinase inhibitors have been used in order to determine which cysteine proteinases are vital 
for the survival of the parasite (Irvine et al., 1997).   The reducing environment of the vagina 
provides a suitable milieu for the activation of cysteine proteinases (Alderete  et al., 1991a; 
Alderete et al., 1991b). 
Trichomonas  vaginalis  has  been  reported  to employ  capping  in  order  to  cleave  host 
immunoglobulins (including IgG), laminin, and haemoglobin, with cysteine proteinases found 
in the supernatants of logarithmically growing cultures (Provenzano & Alderete, 1995; Ryu & 
Min, 2006).    Since T. vaginalis proteinases are capable of degrading various substrates, they 
can  also  degrade  mucin  permitting  the  organism to  traverse  the  mucous  layer  (Lehker  & 
Sweeney, 1999).
In addition to this, cysteine proteinases found on the parasite’s surface are a prerequisite for 
the  adherence  of  T.  vaginalis to  VECs  (Garber  &  Lemchuk-Favel,  1994).   Pre-treating 
trichomonads  with  a  cysteine  proteinase  inhibitor  TLCK  (N-alpha-p-tosyl-L-lysine 
chloromethyl ketone), decreased the parasite’s ability to adhere to epithelial cells.  Incubating 
TLCK-treated parasites with other cysteine proteinases restored the parasite’s ability to adhere 
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(Arroyo  &  Alderete,  1989).   Two  surface  proteinases  CP65  and  CP30,  involved  in 
cytoadherence,  are active at the pH and temperatures found in the vagina during infection 
(Hernandez-Gutierrez  et al., 2004).  Both CP65 and CP30 degrade vaginal proteins, such as 
FN.  However,  only CP30 degrades hemoglobin (Alvarez-Sanchez  et al.,  2000; Mendoza-
Lopez  et  al.,  2000;  Hernandez-Gutierrez  et  al.,  2004).   Hernandez-Gutierrez  et  al. (2004) 
reported that  CP39 binds  to  VECs,  but  not to  prostatic  and colon cancer  cells suggesting 
tissue-specific binding.  Proteinase CP39 was found to degrade immunoglobulins, FN, as well 
as hemoglobin (Hernandez-Gutierrez  et al., 2004).  It has also been suggested, that cysteine 
proteinases inhibit lysis via complement by degrading C3 when deposited on the parasite’s 
surface (Alderete et al., 1995d). 
2.7.6 Cell detaching factor (CDF)
Although  contact-dependent  mechanisms  have  been  shown  to  play  important  roles  in 
pathogenesis, contact-independent mechanisms are also involved.   These mechanisms were 
initially  reported  by  Hogue in  1943,  who studied  the  adverse  effects  cell-free  filtrates  of 
trichomonads had on cells in culture.  Secreted in the cell-free filtrate was a soluble factor, 
named cell  detaching factor (CDF) (Garber  et al., 1989; Garber & Lemchuk-Favel, 1994). 
This soluble factor was found to be a 200 kDa glycoprotein.  This glycoprotein was reported 
to cause cytopathic effects, such as the detachment and clumping of the cell monolayer  in  
vitro  (Pindak  et al., 1986; Garber  et al., 1989).  Cell detaching factor was also capable of 
inhibiting freshly added cells from monolayer formation (Pindak et al., 1986).  The  in vitro 
detachment of cells is considered to be analogous to the shedding of VECs from the vaginal 
mucosa, during acute T. vaginalis infection (Garber et al., 1989), implying that CDF may play 
a role in pathogenesis.
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The CDF concentration in culture filtrates was found to fluctuate depending on three factors. 
These factors include the “duration of  T. vaginalis  growth prior to filtrate preparation,  the 
initial  inoculum of  T. vaginalis,  and pH of the filtrate  prior to harvesting” (Garber  et al., 
1989).  
The optimum pH of the cell-free filtrate  for CDF production was found to be around 7.2 
(Pindak et al., 1986).  However, purified CDF displayed optimum activity at pH 6.5 (Garber 
et  al.,  1989).   Activity  varied  between  pH 5.0  and  pH 8.5  (Garber  et  al.,  1989).    Cell 
detaching factor was also found to be inactive below pH 4.5.  Clinically, this was important 
because the normal vaginal pH is 4.5 and during trichomoniasis the pH is greater than 5.0. 
This rise in vaginal pH during infection may be crucial in the pathogenesis of  T. vaginalis  
(Petrin et al., 1998).
There lies an association between CDF concentration and the severity of clinical  vaginitis. 
However,  it  is  uncertain  whether  the  CDF  level,  its  activity,  its  immunogenecity,  or  a 
combination of the three contributes to the severity of clinical vaginitis.  In fact, all of the 
pathogenic mechanisms possibly contribute to the virulence of this organism.  Estrogen levels 
have been found to affect CDF production.  The severity of symptoms has been shown to 
increase during menses, when estrogen levels are the lowest (Garber et al., 1991).  
CDF seems to play a vital role in the pathogenesis of T. vaginalis.  Therefore, understanding 
its function may help elucidate the organism’s ability to invade, adjust, and adapt to a hostile 





3.1 Growth and maintenance of Trichomonas vaginalis
Trichomonas vaginalis isolates were obtained from patients enrolled in a concomitant study. 
Vaginal  swabs  were  placed  into  Diamond’s  culture  medium.   Organisms  were 
maintained  as stock cultures for several  weeks by passaging in 5mLs of Diamond’s 
trypticase-yeast-extract-maltose  medium  (pH  6)  supplemented  with  10%  heat 
inactivated  horse  serum  with  4µg/mL  amikacin,  1mg/mL  ampicillin  and  5mg/mL 
amphotericin B.  Organisms used in the experiments were in the logarithmic growth 
phase.  This was achieved by subculturing 500µl of T. vaginalis stock culture for 48hrs 
in 5mLs of Diamond’s medium.  Organisms were sub-cultured in agar free media a 
week before experiments in order to prevent clumping.  
3.2 Cell lines 
The  three  cell  lines  used  in  this  study were  purchased  from the  American  Type  Culture 
Collection (ATCC), Virginia (USA).  The vaginal epithelial cell line VK2 (ATCC, catalogue 
number CRL-2616) was derived from normal vaginal mucosal tissue acquired from a 32 year 
old  pre-menopausal  woman  undergoing  vaginal  repair  surgery  in  1996  (Fichorova  & 
Anderson, 1999).  The cervical epithelial cell line ME-180 (ATCC, catalogue number HTB-
33) was derived from a highly invasive cervical squamous cell carcinoma of a 66 year old 
female.  The endometrial cell line KLE (ATCC, catalogue number CRL-1622) was derived 
from a poorly differentiated endometrial adenocarcinoma of a 64 year old female.  Figure 3.1 
shows light microscopic (Nikon Diaphot, Carl Zeis (PTY) Limited) pictures of these three cell 
lines.
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VK2                                        ME-180                                        KLE
Figure 3.1 Vaginal (VK2), cervical (ME-180) and endometrial (KLE) cell lines used in 
experiments (40X)
                                                                                                                        
The culture media used to propagate these cell lines differed due to differences in nutritional 
requirements between the cell lines.  According to ATCC instructions, the VK2 cells required 
Keratinocyte-Serum free medium (GIBCO, catalogue number BRL 17005-042) supplemented 
with 0.1mg/mL human recombinant EGF, 0.05mg/mL bovine pituitary extract and additional
calcium chloride  with a  final  concentration  of  0.4mM.  The  cervical  epithelial  cells  were 
cultured  in  McCoy’s  5a  Medium  containing  1.5mM  L-glutamine  and  2.2g/L  sodium 
bicarbonate.   The endometrial  cells  were grown in a  1:1 mixture  of  Dulbecco’s  modified 
Eagles  medium and Ham’s  F12 medium containing  2.5mM L-glutamine,  1.34g/L  sodium 
bicarbonate  and  2.25g/L  glucose.   The  culture  medium  for  both  ME-180  and  KLE  was
supplemented with heat-inactivated foetal calf serum (FCS).
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3.2.1 Cell propagation 
In resuscitating frozen cells, the cryovial containing the cells was thawed by rapid agitation in 
a water-bath at 370C.  The cryovial was then removed from the water-bath and disinfected 
with 70% ethanol before transfer into the laminar flow cabinet.  Cells were then transferred to 
a 15mLs conical tube, to which 10mLs of the appropriate fresh growth medium was added 
slowly as not to shock the cells.  The cell suspension was then centrifuged (Heraeus multifuge 
3S-R, 2006, Thermo Electron Corporation) at 1200rpm for 10min and the supernatant was 
discarded.   This  was  done  in  order  to  rid  the  cells  of  preservatives,  such  as  dimethyl-
sulphoxide (DMSO) which is cytotoxic.  The pellet of cells obtained was then re-suspended in 
10mLs of fresh growth medium. The cell suspension was then seeded into equilibrated 75cc 
tissue culture treated flasks to which an additional 10mLs of fresh culture medium was added. 
The cells were then incubated at 370C in 5% CO2 until a confluent monolayer was obtained. 
The incubation time varied between four to ten days, depending on the cell line.  Cells were 
maintained every 48hrs with fresh maintenance medium.  
According to the ATCC, the culture media for both KLE and VK2 differed however the media 
used for freezing and resuscitating these cell lines were the same, that being 1:1 mixture of 
Dulbecco’s modified Eagles medium and Ham’s F12, supplemented with 10% FCS, which 
deactivates  the  preservative.   All  cell  lines  were  grown individually,  preventing  possible 




Cell counts were performed using the trypan blue exclusion method.  One part of 1% trypan 
blue dye was gently added to one part of cell suspension.  Only the dead cells stained blue, 
whereas the viable cells remain unstained.  
                                                                  
Figure 3.2 Counting grids of a Neubauer Haemocytometer
A Neubauer Haemocytometer was filled with 10µl of the cell-dye suspension and all the dead
as well as the viable cells were counted as soon as the cells had settled.  
The number of cells per mL was calculated using the following formula: -
N = Number of viable cells counted    X 2
                Number of squares
                                                                            
The factor 2 corrects for the dilution with trypan blue.                 
Example: If you count 50 viable cells in the four corner squares shown in Figure 3.2, then, 
                  Number of cells = 50  x 2 x 104 cells/mL
                                                 4
                                            = 25 x 104 cells/mL
                                            = 2.5 x 105 cells/mL
The percentage viability was determined using the following formula: -
% cell viability =   Number of viable cells counted     X 100
              Total number of cells counted
(Source: http://www.nuncbrand.com/en/frame.aspx?ID=1174)
Number of cells = N x dilution factor x dilution volume
Cells counted within corner grids
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3.2.3 Passaging of cells
Once  attaining  confluency,  the  monolayer  was  trypsinized  using  a  combination  of  the 
proteolytic enzyme trypsin and ethylene-diamine-tetra-acetc acid (EDTA).  Trypsin degrades 
the extracellular tissue protein matrix, which aids cells in adhering to each other.  Ethylene-
diamine-tetra-acetic  acid  is  a  chelating  agent,  removing  the magnesium and calcium ions, 
which are needed for the attachment of cells to the plastic flask wall.
To achieve this, old medium was discarded and cells were washed three times with warm 
phosphate buffered saline (PBS).  Pre-warmed trypsin-EDTA was added and dispersed evenly 
by gently rocking the flask.   The flask was then incubated for 1 to 3min (depending on the 
cell line) at 370C.  Trypsin is harmful to living cells; therefore cells were exposed for the 
shortest possible time.  The flask was then tapped against the palm of the hand, to assist in cell 
detachment.   The effect  of trypsin was then counteracted by the addition of the respective 
growth medium supplemented with 10% FCS, as soon as the cells were detached.
Since VK2 cells grow in serum-free medium only, the cell suspension containing FCS was 
centrifuged.   After  which,  the  supernatant  was  discarded  and  the  cells  re-suspended  in 
keratinocyte-serum free culture medium.
The cell lines were sub-cultured according to ATCC instructions.  The cell concentration was 
adjusted to the desired concentration according to a predetermined ratio of 1:3 to 1:5 for VK2, 
1:2 to1:3 for KLE and 1:3 to 1:8 for ME-180.  To avoid loss of differentiation, these cell lines 
were not split at very high ratios.  Cells were then seeded into new flasks, which were then 
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incubated in 5% CO2 at 370C for 48hrs, during which these cells repaired their membranes and 
multiplied forming a monolayer. 
3.2.4 Cryopreservation of cells
Freezing fluid containing 85% culture medium, 10% FCS and 5% DMSO was added to the 
cell suspension, slowly as not to shock the cells.  This was followed by a step-wise process, 
during which, the cells were placed at 40C for one hour, -200C overnight and thereafter at 
-700C (for up to three months) or storing in liquid nitrogen at –1960C.  
3.3 The effect of pH on the growth and survival of T.  vaginalis 
In studying the effect pH has on  T. vaginalis, portions of the Diamond’s medium used was 
modified with 1N HCl and 1N NaOH so that the pH ranged from 4.5 to 7 in increments of 0.5. 
For the assay,  500µl  of  cultured  T. vaginalis was added to 5mLs of modified Diamond’s 
medium and incubated at 370C in 5% CO2 for 48hrs.  Cell counts were performed at 0, 24 and 
48hrs intervals.  The pH was recorded at 0, 4, 8, 24 and 48hrs intervals.
3.4 Binding medium
To be able to study the adhesion of the protozoa to the cells, a medium needed to be developed 
that  supported  both  the  parasites  and  the  cell  line  used.   This  was  achieved  by  mixing 
Diamond’s medium with the cell  specific tissue culture medium in a ratio of 1:2.  This is 
referred to as “binding medium” (Alderete & Garza, 1985; Arroyo & Alderete, 1989).
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3.5 Effects of environmental changes
Since the pH in the vagina changes during the menstrual cycle, adhesion of trichomonads was 
studied at different pH reflecting these changes.  Portions of the binding medium were 
modified with 1N HCl and 1N NaOH so that the pH ranged from 4.5 to 7 in increments 
of 0.5.  
In addition,  we studied the difference in adhesion at  surface (330C) and core (370C) body 
temperature.  All tests were done three times in triplicate. 
3.6 Adhesion assay
In developing an adhesion assay (Alderete & Garza, 1985; Arroyo & Alderete, 1989), cells 
were seeded on 12mm glass coverslips in the wells of 24 well micotiter plates.  These were 
incubated in 5% CO2 at 370C until reaching 90% confluency.  The culture medium was then 
aspirated and cells were washed three times with 2mls of warm sterile PBS.  Following this, 
1ml of parasite suspension (in modified binding medium containing the predetermined number 
of trichomonads) was added to the confluent cell monolayers.  Cells and trichomonads were 
then co-incubated for 1hr in 5% CO2 at the required temperature.  After incubation, unbound 
trichomonads were removed by washing three times with 2mls of warm sterile PBS.  The 
coverslips  were  removed,  stained  with  acridine  orange  and  viewed  under  a  fluorescent 
microscope  (DF  Nikon  Labophot,  Carl  Zeiss  (PTY)  Limited).   The  number  of  adhered 
trichomonads per 100 cells was counted.
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3.7 Cytotoxicity studies
Cytotoxicity assays were done in the wells of a Costar 96 well tissue culture treated microtiter 
plate,  in  triplicate  as  shown in  Figure  3.4.   Cells  were  seeded  into  individual  wells  and 
incubated in 5% CO2 at 370C until reaching 90% confluency.  Empty wells were filled with 
sterilized water, in order to maintain moisture.  Cell counts were performed for each cell line, 
in  order  to  determine  the  inoculum.   Prior  to  inoculation,  the  cell  culture  medium  was 
aspirated and cells were washed three times with warm sterile PBS.  Following this, 100µl of 
parasite suspension in binding medium with different pH was added to the cell monolayers, at 
the desired multiplication of infection (MOI).  The inoculated monolayers were incubated for 
6hrs  in  5%  CO2 at  370C.   Control  wells  contained  cells  only.   Cytotoxicity  was  then 
quantitatively  measured  using  the  non-radioactive  Cytotox  96 assay  kit  from  Promega 
(Bastida-Corcuera et al., 2005).
The Cytotox  96 Assay quantitatively measures  lactate  dehydrogenase  (LDH),  a cytosolic
enzyme that is released upon cell lysis.  The amount of LDH released in culture supernatants 
was measured with a 30mins enzymatic assay in which LDH converts tetrazolium salt (INT) 
to  red formazan.   The color  intensity is  proportional  to  the amount  of released LDH and 
through that, to the number of lysed cells.  This was measured by means of spectrophotometry 
at 490nm on a 96 well plate reader (Anthos Reader, 2001, SepSci Technical Services Ltd).
Figure 3.3 shows the 96 well assay plate layouts as used for each cell line at different pH (4.5 
to 7), with the contents of the different wells shown in different colours.
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Plate 1
                                           1       2       3       4       5       6       7       8       9      10     11     12
                      
               
                          
                                                pH =        7     6.5      6     5.5      5     4.5      7     6.5      6     5.5      5      4.5
                           
                               
Plate 2
1       2       3       4       5       6       7       8       9      10     11     12
                                                pH =        7      6.5      6     5.5      5     4.5     
      
Figure 3.3 Lay-out of the cytotoxicity assay plates. Red: wells with trichomonads (effector) 
only.  Blue: wells with cells (target) only.  Green: Maximum (100%) release of LDH by cells 
only.  Orange: Volume correction control, which corrects for the volume change caused by 
adding lyses solution.  Purple: culture medium background, which corrects for LDH activity 
contributed by both the serum and the varying amounts of phenol red in the culture medium.
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Forty five minutes prior to the end of the incubation time, 10µl of lysis solution was added for 
every  100µl  of  target  cells  to  the  wells  marked  as  Target  Cell  Maximum  LDH Release
Control.   After  incubation,  the  plates  were  centrifuged  (Heraeus  multifuge  3S-R,  2006, 
Thermo Electron Corporation) at 4000rpm for 4min.
In  measuring  the  LDH  concentration,  50µl  aliquots  of  supernatant  from  all  wells  were 
transferred to a fresh 96 well enzyme assay plate, to which 50µl of Substrate Mix was added. 
The plate was then covered with foil, to protect it  from light, and incubated for 30mins at 
room temperature.   Thereafter, 50µl of Stop Solution was added to each well and absorbance 
values were recorded within 1hr.  All reagents were provided with the kit.  The following 
formula was used to calculate the percentage of cytotoxicity:
          experimental – effector spontaneous – target spontaneous  x 100  
                           target maximum – target spontaneous 
                
                                                              (effector = trichomonads; target = tissue culture cells)
(Source: http://www.promega.com/catalog/category.aspx?catergoryname=productgroup_39)
3.8 Data analysis
Trend analysis and statistical significance was determined using SPSS version 15.0 (SPSS 
Inc., Chicago, Illinois).  A p value <0.05 was considered as statistically significant.  Multiple 
comparisons between each pH of each cell line were done.  Dependant variables were tested
using histograms and the skewness statistic.  
3.9 Ethical consideration
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4.1 Growth and Survival of T. vaginalis at different pH values
The effect of pH on the growth and survival of T. vaginalis is summarised in Figure 4.1.  At 
48hrs,  the concentration of  T. vaginalis  increased sharply between pH 5.5 and 7 with the 
maximum number of viable organisms between pH 6 and 6.5.  Most of the organisms in the 
first 24hrs at pH 4.5 had died, thus indicating the importance of environmental pH.  There was 
also a marked increase of pH 5 and pH 5.5 to pH 6 at 24hrs.
In analyzing these growth and survival data, more than twice the standard error of skewness 
indicated significant skewness. The dependant variables were therefore log-transformed due to 
abnormality.  Two-way ANOVA testing  was  used  to  assess  the  full  factorial  model.  Both 


































 Figure 4.1 Growth and survival results of T. vaginalis sub-cultured in media of different pH 
(4.5 to 7) over a 48hrs period.  The number of viable organisms was counted at 0, 24 and 
48hrs, p<0.001.
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4.2 Adherence of T. vaginalis to cell monolayers
Figure 4.2 shows acridine orange stained cells exposed to T. vaginalis.  
                                        
Figure 4.2  Acridine orange stain of the KLE cell line with adhered  T. vaginalis (40X).  T. 
vaginalis can be easily distinguished against the dark orange background of cells.  
The inter- and intra-test variation for the adhesion assays for all three cell lines at 370C and 
330C is shown in Tables 4.1 and 4.2.  The percentage adherence of T. vaginalis to the different 




Table 4.1: Triplicate values of adherent trichomonads for three tests done on different days at 370C.
pH Cell line Test 1 Test 2 Test 3
pH7 VK2 10.5 8.5 9 8.5 7.5 8 5.5 6.5 5.5
pH6.5 VK2 8 7.5 7.5 6 6.5 6 5 5.5 4.5
pH6 VK2 6 5.5 5.5 4.5 5.5 5 5 4.5 4
pH5.5 VK2 5 4 5.5 4.5 5 4 4.5 4.5 4
pH5 VK2 8 5.5 6.5 6 5.5 5.5 6 5.5 5.5
pH4.5 VK2 4.5 4.5 4.5 4.5 4 4 4 3.5 4
pH7 ME-180 8 7 7 7 6 5.5 5 4.5 4.5
pH6.5 ME-180 9.5 8 8.5 7 7 7.5 6 6.5 5.5
pH6 ME-180 4 4 4.5 3.5 4 4 3.5 3 3
pH5.5 ME-180 4.5 5 4 4 4 3.5 4 3.5 3.5
pH5 ME-180 2.5 4 2 2.5 2 2.5 2.5 2 3
pH4.5 ME-180 1 1.5 1.5 2 2 2 2 1.5 1.5
pH7 KLE 6 5 4.5 5.5 4.5 4 4.5 4 4
pH6.5 KLE 6 7.5 5.5 5.5 5 5 4.5 4.5 4
pH6 KLE 8 9 8 7.5 8 7.5 7 7 7.5
pH5.5 KLE 5 6.5 5 5.5 5.5 4.5 5 5.5 5
pH5 KLE 9.5 6 10 8.5 8 7.5 8 8 8
pH4.5 KLE 9 7.5 9.5 9 8 8 8.5 8.5 8
Table 4.2: Triplicate values of adherent trichomonads for three tests done on different days at 330C.
pH Cell line Test 1 Test 2 Test 3
pH7 VK2 7.5 7 8 7.5 7 8 7.5 7 8
pH6.5 VK2 8 8.5 8 8 8.5 8 8 8.5 8
pH6 VK2 8.5 8.5 9 8.5 8.5 9 8.5 8.5 9
pH5.5 VK2 11 10.5 10 11 10.5 10 11 10.5 10
pH5 VK2 12.5 13.5 14 12.5 13.5 14 12.5 13.5 14
pH4.5 VK2 13.5 13.5 14 13.5 13.5 14 13.5 13.5 14
pH7 ME-180 6.5 6.5 7 6.5 6.5 7 6.5 6.5 7
pH6.5 ME-180 8 8 7.5 8 8 7.5 8 8 7.5
pH6 ME-180 7.5 8 7.5 7.5 8 7.5 7.5 8 7.5
pH5.5 ME-180 14 13 13 14 13 13 14 13 13
pH5 ME-180 19.5 19.5 19 19.5 19.5 19 19.5 19.5 19
pH4.5 ME-180 20.5 20 20.5 20.5 20 20.5 20.5 20 20.5
pH7 KLE 3.5 4 4 3.5 4 4 3.5 4 4
pH6.5 KLE 3 3 2.5 3 3 2.5 3 3 2.5
pH6 KLE 1 2 1.5 1 2 1.5 1 2 1.5
pH5.5 KLE 1.5 1 1.5 1.5 1 1.5 1.5 1 1.5
pH5 KLE 1.5 1.5 1 1.5 1.5 1 1.5 1.5 1
pH4.5 KLE 3 2.5 2.5 3 2.5 2.5 3 2.5 2.5
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Adherence to VK2 cells at 370C varied from an average of 4.2 trichomonads/100 cells at pH 
4.5 to 7.7/100 cells  at  pH 7.  At 330C these values were 13.7/100 cells  and 7.5/100 cells 
respectively.   For ME-180 cells the average number of adherent trichomonads at 370C was 
1.7/100 cells at pH 4.5 and 6.1/100 cells at pH 7.  At 330C the averages were 20.3/100 cells 
and 6.7/100 cells at the respective pH values.  Adherence to KLE cells at 370C varied from an 
average of 8.4 trichomonads/100 cells at pH 4.5 to 4.7/100 cells at pH 7.  At 330C these values 
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  Figure 4.3 Adhesion assay results displaying the average number of trichomonads adhered to 
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  Figure 4.4 Adhesion assay results displaying the average number of trichomonads adhered to 
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 Figure 4.5 Adhesion assay results displaying the average number of trichomonads adhered to 


























  Figure 4.6 Adhesion assay results displaying the average number of trichomonads adhered to 
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  Figure 4.7 Adhesion assay results displaying the average number of trichomonads adhered to 
  the ME-180 cell line between pH 4.5 to 7 at 330C, p<0.001. 
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  Figure 4.8 Adhesion assay results displaying the average number of trichomonads adhered to 
  the KLE cell line between pH 4.5 to 7 at 330C, p<0.001. 
There was an overall significant difference between the cell lines (p<0.001).   While at 370C 
for both the VK2 and ME-180 cells adherence levels increased with rising pH, with the KLE 
cells the opposite trend was observed.  At 330C, adherence to both the vaginal and cervical 
cells decreased at a higher rate with rising pH.  The adherence to the KLE cell line at 330C 
decreased.   The  comparison  of  mean  adhesion  at  the  two  temperatures  was  found  to  be 
significantly different (p=0.009).  Adhesion at 330C was higher as compared to 370C for both 
the  VK2  and  ME-180  cells  but  not  for  the  KLE  cells.   There  was  a  higher  significant 
interaction between all three variables (p<0.001).  Therefore the effect of each factor depends 
on the effects of the other factors.  The cell lines behave differently over the different pH 
values and the different temperatures.  Overall, all three variables (cell line, temperature and 




After 30mins post-inoculation, most trichomonads settled on the cell monolayers.  After 2hrs 
they lay motionless, adhered to the cell monolayers.  Eight hours later approximately 10% of 
the cell monolayers were destroyed.  Cells that were free of the trichomonads lay next to those 
already destroyed indicating the importance of contact between the parasite and the host cell. 
Extended exposure of the cell monolayers to live trichomonads resulted in total loss of cell 
viability.  The cytotoxicity of T. vaginalis is therefore a slow process which requires several 
hours of contact with the cell monolayers (Gilbert et al., 2000).  
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4.3.2 LDH release assay
The percentage cell death was measured by means of the LDH release assay.  The results for 
each cell line are given in Table 4.3 and are summarized in Figures 4.9 to 4.11.
Table 4.3: Percentage LDH release by different cell lines for the three experiments done on 
different days.
Cell line pH Test 1 Test 2 Test 3
VK2 4.5 10.71 15.48 1.99
VK2 5 52.51 38.99 55.21
VK2 5.5 55.92 61.22 64.08
VK2 6 32.79 28.19 32.87
VK2 6.5 50.92 53.37 41.1
VK2 7 12.97 23.27 31.26
ME-180 4.5 60.48 84.75 55.4
ME-180 5 40.64 33.56 38.54
ME-180 5.5 42.74 43.63 41.68
ME-180 6 29.72 29.65 30.14
ME-180 6.5 7.49 7.11 9.32
ME-180 7 8.19 7.24 9.24
KLE 4.5 -11.62 -10.42 -1.42
KLE 5 25.52 47.93 94.99
KLE 5.5 6.08 21.96 29.37
KLE 6 -4.88 0.82 10.43
KLE 6.5 3.87 0.44 13.29
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 Figure 4.9 Cytotoxicity assay results displaying the average toxicity values of T. vaginalis on 
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  Figure 4.10 Cytotoxicity assay results displaying the average toxicity values of T. vaginalis 
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 Figure 4.11 Cytotoxicity assay results displaying the average toxicity values of T. vaginalis   
 on the KLE cell line between pH 4.5 to 7 at 370C, p<0.001. 
The  comparison of mean cytotoxicity values between the cell lines had a highly significant
overall difference (p<0.001).  The difference lay between ME-180 and each of the other two 
cell  lines  (p<0.001).   The  VK2  and  KLE  cell  lines  were  not  different  from each  other 
(p=0.012).  The rate of change over pH between the cell lines differed significantly (p<0.001). 
The cytotoxicity of T. vaginalis to the ME-180 and KLE cell lines decreased with rising pH. 
The VK2 cell line was not affected by pH, although there was a sharp increase in cell death at
the lower pH (4.5 to 5) and thereafter stabilizes.  The interaction between all three variables 





For many years, the question regarding  T. vaginalis  involvement in infections of the female 
upper genital tract remained unresolved.  This study aimed at contributing to the resolution of 
whether  T. vaginalis  is able to adhere to cells of the endometrium, and if this differs from 
adhesion to cells of the vagina and cervix.  In addition, toxicity to these different cell types 
was compared.  So far, the ability to adhere to vaginal epithelial cells, the cytotoxic effect on 
those cells and proteinase activity has been proposed as factors involved in the pathogenecity 
of trichomoniasis (Ryu & Min, 2006).
A vaginal infection with T. vaginalis usually starts when the pH is at its physiological value of
4.5 but during progression of the infection, the pH increases (Petrin et al., 1998; Adegbaju & 
Morenikeji, 2008).  Before embarking on studies of interaction between the parasites and the 
different host cell types, the viability and growth of the organism at different pH values was 
investigated.   There  seem to  be  two subpopulations  of  parasite  cells.   The  majority  died 
quickly at pH 4.5 but survival and growth rates improve with increasing pH.  This confirms
the need for the organisms to adjust the pH in the vagina to establish infection.  Kostara et al. 
found that growth rate of T. vaginalis was pH dependent.  A higher pH delayed the initiation 
of  growth  whereas  a  lower  pH  favoured  growth  and  survival  in  the  early  decline  phase 
(Kostara et al., 1998).  
Adherence  is  a  pre-requisite  to  establish and in  many infections  to maintain  an infection. 
Experiments exposing immortalised host cell lines to microbes have been employed to study 
this  phenomenon  (Garcia  et  al.,  2003;  Bastida-Corcuera  et  al.,  2005).   Many  of  these 
experiments were done with cells either from non-human origin or those originating from an 
anatomical site not related to the site where the organism resides when causing disease.  In
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addition, most of these cell lines had lost their typical characteristics, which they expressed in  
vivo  during the immortalisation process. Often, the type of culture strains used might have 
adjusted to growth in vitro and therefore, had lost important characteristics.  In this study, cell 
lines were used from the anatomical sites that potentially can be infected with  T. vaginalis. 
The organisms used were fresh clinical isolates and were therefore not the same in all the 
experiments.  This is because T. vaginalis does not survive long in culture media and can only 
be passaged for a limited number of times.  This might in part be responsible for variation in 
the observations.  However, sub-culturing of trichomonads in vitro may affect the virulence of 
the pathogen.  Trichomonads sub-cultured for several weeks were shown to synthesize lower 
amounts of adhesion proteins (Garcia & Alderete, 2007) resulting in possible loss of virulence. 
Trichomonas vaginalis produces five surface proteins involved in adherence to human vaginal 
epithelial cells (VECs).  These are named Adhesin Protein (AP) 120, AP65, AP51, AP33, and 
AP23.   Protein AP65 is the most prominent adhesin of T. vaginalis (Garcia et al., 2003) and 
appears to play a role in establishing infection.   In 2004, Mundodi  et al. found that down 
regulating the expression of AP65 decreases adherence of T. vaginalis to VECs (Mundodi et  
al.,  2004).   Therefore,  the  characterization  of  this  adhesin  may  lead  to  possible  future 
intervention strategies.
An infection with T. vaginalis in the vagina involves detachment of cells from the vaginal wall 
known as sloughing (Petrin  et al., 1998).  In vitro  detachment of cells from solid phase on 
which they grow is observed almost invariably on exposure to extra-cellular microbes.  The 
question of whether  this  is  equivalent  to  the  in  vivo  phenomenon of  sloughing cannot  be 
answered. 
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This  study  focused  on  the  differences  in  adhesion  and  toxicity  to  vaginal,  cervical  and 
endometrial  cells.   The  main  aim was  to  establish  whether  they  can  adhere  and  damage 
endometrial cells to at least the same extend as the other cells which are known to be affected 
by the parasite in vivo.  This was done under different circumstances including the pH range 
found  in  the  vagina  when  the  infection  develops  as  well  as  temperatures  reflecting  the 
difference between the surface temperature of the body and the core temperature.  
The adhesion to vaginal and cervical epithelial  cells was similar with a trend of decreased 
adhesion  at  higher  pH.   On  the  other  hand,  adhesion  to  the  endometrial  cells  was  not 
influenced by pH.  However, the number of adhering trichomonads per 100 cells tended to be 
higher for endometrial cells as compared to the other two cell types (no literature is available 
to confirm this).  
Regarding cytotoxicity, the highest level for cells of the lower genital tract was found at the 
lowest pH, in particular on cervical cells.  This suggests rapid damage shortly after acquisition 
of the infection.  This in turn, assists in neutralising the pH creating optimal circumstances for 
adhesion and multiplication (no literature is available to confirm this).  
In 2002, Moodley  et al.  reported an association with  T. vaginalis and PID in HIV positive 
women but not in HIV negative women (Moodley  et al., 2002).  They speculated about the 
pathophysiology of this phenomenon.  Trichomonas vaginalis could invade the upper genital 
tract  in  a  higher  percentage  of  HIV  infected  women  because  of  the  evolving  immune 
incompetence.  Although the CD4 counts of the women involved were not known, it has been 
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well established for tuberculosis that susceptibility to infection increases at CD4 counts far 
above those associated with immune suppression (Grant et al., 2007).  The other option is that 
HIV infection enhances the penetrability of the cervical mucus plug as initiated by mucinases 
produced  by  T.  vaginalis.   This  in  turn,  allows  ascending  infection  by  T.  vaginalis with 
bacteria present in the vagina or by the bacteria only.  The observation of this study adds value 
to the last option.  The protozooan adheres in at least the same quantities to endometrial cells 
as to cells of the lower genital tract and exerts cytotoxicity,  especially at pH 5 to 6.  This 
indicates that T. vaginalis may be directly involved in infection of the upper genital tract.  The 
inflammatory  response  to  bacterial  co-infection  could  be  lowering  the  pH  to  levels  that 
optimize the toxic effect of T. vaginalis (no literature is available to confirm this)..
Regarding pathogenesis of trichomoniasis, the observations of this study remains speculative 
and does not explain the role of HIV.  Although observations  in vivo are difficult to obtain, 
these are needed to understand this fully.  Adhesion and cytotoxicity studies provide insight 
for studying the pathogenesis of T. vaginalis hopefully leading to therapeutic treatment and the 
prevention of trichomonal infections.
In conclusion, adhesion of trichomonads to the endometrial cell line suggests that T. vaginalis 
is  capable  of  colonization  of  the upper  genital  tract.   At  pH values  applicable  to  in  vivo 
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APPENDIX I –T. VAGINALIS AND TISSUE CULTURE MEDIA
1.1 Diamond’s trypticase-yeast-extract-maltose medium
Trypticase                                                20g               
Yeast extract                                            10g
* Glucose                                                 10g
* Maltose                                                  5g
* Agar                                                       0.5g
L. cysteine                                                1g
L. ascorbic acid                                        0.2g
Distilled water (DH2O)                            900mL
* For agar free media, maltose and agar were substituted with glucose.
Dry ingredients were weighed out and dissolved in DH2O.  The media was adjusted with 1N 
HCl  and  1N  NaOH  to  pH  6  and  autoclaved  for  10mins.   Once  cooled,  100mL  of  heat 
inactivated horse serum and antibiotics (4µg/mL amikacin, 1mg/mL ampicillin and 5mg/mL 
amphotericin B) were added.
1.2 Antimicrobial solution
Amikacin                                                   4µg/mL
Ampicillin                                                 1mg/mL
Amphotericin B                                         5mg/mL
Ampicillin  and  amphotericin  B  were  dissolved  in  4mLs  and  10mLs  of  sterile  DH2O 
respectively.  One milliliter aliquots of each antibiotic was stored at -200C.
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1.3 Horse serum and Foetal calf serum (FCS)
Horse serum and foetal calf serum was used in Diamond’s and cell culture media respectively. 
These  were  heat  inactivated  by  de-complementing  at  560C for  1hr.   This  was  then  filter 
sterilized, aliquoted into 10mL tubes and stored at -200C.  Quality control was carried out by 
incubating 5mLs of serum at 370C for one week.
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APPENDIX II – SOLUTIONS AND REAGENTS
2.1       0.025% Trypsin-EDTA
            0.05% EDTA (0.05g EDTA was dissolved in 100mLs PBS and filter sterilized)
            0.25% Trypsin
            PBS (pH 7)
EDTA was diluted in a ratio of 1:1 in PBS.  A mixture of 1mL trypsin and 4mLs of diluted 
EDTA was filter sterilized, aliquoted in 2mLs eppendorfs and stored at -200C.
2.2       Acridine orange stain
            0.2g Acridine orange powder
            20mL of DH2O 
            0.2M Acetate buffer (made up of 0.2M acetic acid and 0.2M sodium acetate, pH 4)
Stock solution was made up by dissolving acridine powder in DH2O.  This was aliquoted in 
20mLs tubes, covered with foil and stored at 40C.  Working solutions containing 0.5mL stock 
solution and 5mLs 0.2M acetate buffer was made fresh daily.  Cover slips were air dried, heat 
fixed and flooded with acridine orange stain for 2mins.  After 2mins, coverslips were rinsed 
with tap water and allowed to air dry. 
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2.3      Non-radioactive Cytotox 96  assay kit from Promega 
           Substrate mix (powder)
           Assay buffer
           LDH positive control
           Lysis solution (10X)
           Stop solution
The following controls were performed with the Cytotox 96 assay: -
      1.   Effector Cell Spontaneous LDH Release: corrects for the spontaneous release of LDH  
            from effector cells (trichomonads).
      2.   Target Cell Spontaneous LDH Release: corrects for spontaneous release of LDH from 
            target cells (tissue culture cells).
3. Target Cell Maximum LDH Release: required in calculations to determine 100%   
      release of LDH.
4. Volume Correction Control: corrects for the volume change caused by adding lysis 
solution.
5. Culture Medium Background: corrects for LDH activity contributed by the serum in 
culture medium and the varying amounts of phenol red in the culture medium.
The Substrate Mix was dissolved in 12mLs of warm Assay Buffer.  The Substrate Mix was 
protected  from light  and  stored  at  -200C for  ≤6 to  8  weeks.   One bottle  of  reconstituted 
Substrate Mix was enough for two 96 well plates.
(Source: http://www.promega.com/catalog/category.aspx?categoryname=productgroup_39)
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